Misleading tacrolimus concentration value in blood taken from a catheter used for tacrolimus administration

American Journal of Health-System Pharmacy

Volumn 65, Issue 3, 2008, Pages 226-228

  Grouzmann, Eric ^a   Buclin, Thierry ^a   Biollaz, Jérôme ^a  

^a University of Lausanne Medical Center   (Switzerland)

Author keywords

Blood levels; Catheters; Contamination; Immunosuppressive agents; Lung diseases; Tacrolimus; Transplantation

Indexed keywords

SODIUM CHLORIDE; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; BLOOD SAMPLING; CASE REPORT; CENTRAL VENOUS CATHETER; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTINUOUS INFUSION; DRUG BLOOD LEVEL; DRUG DETERMINATION; FEMALE; HUMAN; LUNG TRANSPLANTATION; NEPHROTOXICITY; NEUROTOXICITY; PRIORITY JOURNAL; VENOUS BLOOD; BLOOD; CENTRAL VENOUS CATHETERIZATION; MIDDLE AGED;

CATHETERIZATION, CENTRAL VENOUS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG TRANSPLANTATION; MIDDLE AGED; TACROLIMUS;

EID: 38749109322     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp070054     Document Type: Article

References (18)

1. Starzl TE, Todo S, Fung J et al. FK 506 for liver, kidney, and pancreas transplantation. Lancet. 1989; 2:1000-4.
2. Alessiani M, Cillo U, Fung JJ et al. Adverse effects of FK 506 overdosage after liver transplantation. Transplant Proc. 1993; 25(1, pt. 1):628-34.
3. Venkataramanan R, Swaminathan A, Prasad T et al. Clinical pharmacokinetics of tacrolimus. Clin Pharmacokinet. 1995; 29:404-30.
4. Kershner RP, Fitzsimmons WE. Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation. Transplantation. 1996; 62:920-6.
5. Shaefer MS, Collier DS, Haven MC et al. Falsely elevated FK-506 levels caused by sampling through central venous catheters. Transplantation. 1993; 56:475-6.
6. Jain AB, Pinna A, Fung JJ et al. Capillary blood versus arterial or venous blood for tacrolimus monitoring in liver transplantation. Transplantation. 1995; 60:512-4.
7. Grenier FC, Luczkiw J, Bergmann M et al. A whole blood FK 506 assay for the IMx analyzer. Transplant Proc. 1991; 23:2748-9.
8. Shulman RJ, Ou C, Reed T et al. Central venous catheters versus peripheral veins for sampling blood levels of commonly used drugs. JPEN J Parenter Enteral Nutr. 1998; 22:234-7.
9. Leson CL, Bryson SM, Giesbrecht EE et al. Therapeutic monitoring of cyclosporine following pediatric bone marrow transplantation: problems with sampling from silicone central venous lines. Ann Pharmacother. 1989; 23:300-3.
10. De Witte T, Hoitsma A, Manoiu MM et al. Monitoring of cyclosporin during continuous intravenous administration. Bone Marrow Transplant. 1986; 1:147-50.
11. Blifeld C, Ettenger RB. Measurement of cyclosporine levels in samples obtained from peripheral sites and indwelling lines. N Engl J Med. 1987; 317:509. Letter.
12. Carreras E, Lozano M, Deulofeu R et al. Influence of different indwelling lines on the measurement of blood cyclosporin A levels. Bone Marrow Transplant. 1988; 3:637-9.
13. Lorenz RG, Garrett N, Turk JW et al. Problems with therapeutic monitoring of cyclosporine using silicone central venous line samples. Transplantation. 1991; 52:1109-10.
14. Brinch L, Evensen S, Albrechtsen D et al. Fooled by blood cyclosporin levels. Bone Marrow Transplant. 1992; 9:77-8.
15. Duffner U, Bergstraesser E, Sauter S et al. Spuriously raised cyclosporin concentrations drawn through polyurethane central venous catheter. Lancet. 1998; 352:1442. Letter.
16. Senner AM, Johnston K, McLachlan AJ. A comparison of peripheral and centrally collected cyclosporine A blood levels in pediatric patients undergoing stem cell transplant. Oncol Nurs Forum. 2005; 32(1):73-7.
17. Busca A, Miniero R, Vassallo E et al. Monitoring of cyclosporine blood levels from central venous lines: a misleading assay? Ther Drug Monit. 1994; 16(1):71-4.
18. Claviez A, Glass B, Dreger P et al. Elevated blood drug levels obtained from indwelling silicon catheters during oral cyclosporine A administration. Bone Marrow Transplant. 2002; 29:535-6.